HSBC downgraded Novo Nordisk (NVO) to Hold from Buy with a DKK 300 price target
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk falls -8.7%
- Prothena price target raised to $8 from $4 at BofA
- Video: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
- Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results
- Novo Nordisk Stock (NVO) Plunges After Alzheimer’s Drug Trial Misses Key Goal